Featured Therapeutics Seek Labs Publishes Editorial Review on the Future of CRISPR Antivirals in an Era of AI-Designed Viral Threats Bridget Baldwin December 8, 2025
Therapeutics CRISPR Treatments for AI-Designed Synthetic Viruses: Rapid Programmable Countermeasures for Emerging and Engineered Viruses Bridget Baldwin December 5, 2025
Featured Therapeutics Seek Labs Publishes First Peer-Reviewed Paper Demonstrating A CRISPR-Based Therapeutic Is Effective Against African Swine Fever Bridget Baldwin November 17, 2025
Blog Featured Next Generation CRISPR: How Seek Labs’ Programmable Therapeutics Are Expanding the Promise of CRISPR-Powered Innovation Bridget Baldwin October 23, 2025
Featured Therapeutics Seek Labs Expands Global Disease Atlas with Mapping of Hemorrhagic Fever Viruses through BioSeeker™ Bridget Baldwin October 21, 2025
Featured Therapeutics Seek Labs Advances Development of Pan-Orthopoxvirus Therapeutic with BioSeeker™ and PTAP™ Bridget Baldwin October 7, 2025
Diagnostics Featured Seek Labs VP of Research, Dr. Anindita Roy, Honored with 2025 Women Tech Council Rising Star Award Bridget Baldwin October 6, 2025
Corporate Featured Seek Labs Selected as Participant of ARPA-H Investor Catalyst Hub Spoke Network and Rapid Response Partnership Vehicle (RRPV) Bridget Baldwin September 23, 2025
Featured Therapeutics Seek Labs Maps Foot-and-Mouth Disease with BioSeeker™ Bridget Baldwin September 9, 2025
